Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation

@article{Seliger2006MolecularMO,
  title={Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation},
  author={B. Seliger and U. Ritz and F. Soldano},
  journal={International Journal of Cancer},
  year={2006},
  volume={118}
}
In humans as in other animal species, CD8+ cytotoxic T lymphocytes (CTLs) play an important if not the major role in controlling virus‐infected and malignant cell growth. The interactions between CD8+ T cells and target cells are mediated by human leukocyte antigen (HLA) class I antigens loaded with viral and tumor antigen‐derived peptides along with costimulatory receptor/ligand stimuli. Thus, to escape from CD8+ T‐cell recognition and destruction, viruses and tumor cells have developed… Expand
CLASS I MOLECULES - ENEMIES OR FRIENDS POTENTIAL IMMUNE ESCAPE MECHANISMS OF TUMORS: MHC
TLDR
The knowledge about the strategies essential for proper MHC class I surface expression has an important impact on the mode of immunotherapies implemented for the treatment of tumor patients. Expand
Immunotherapy of MHC class I-deficient tumors.
  • M. Reinis
  • Biology, Medicine
  • Future oncology
  • 2010
TLDR
Successful immunotherapeutic and vaccination protocols should be optimized against tumors with distinct cell surface expression of the MHC class I molecules, which represents a serious obstacle to the development of effective antitumor immunotherapy or vaccination. Expand
Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition
TLDR
A replication-deficient adenoviral vector carrying human β2m gene is characterized, which is efficient in recovering proper tumor cell surface HLA class I expression in β2M-negative tumor cells without compromising the antigen presentation machinery. Expand
Different regulation of MHC Class I antigen processing components in human tumors
  • B. Seliger
  • Biology, Medicine
  • Journal of immunotoxicology
  • 2008
TLDR
The lack or suppression of MHC Class I surface expression due to antigen-processing deficiencies are accompanied by reduced recognition and lysis by antigen-specific cytotoxic T-lymphocytes, which is further often associated with disease progression. Expand
Modulation of HLA expression in human cytomegalovirus immune evasion.
TLDR
The knowledge about hCMV modulating HLA expression could benefit us to further understand the pathogenesis of viral diseases and may eventually develop novel effective immunotherapies to counteract viral infections and viral associated diseases. Expand
HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation
TLDR
The concept of altered HLA expression as a mechanism exploited by tumors to escape immune control and induce an immunosuppressive environment is reviewed. Expand
Beta-2-microglobulin gene transfer in hla class i deficient tumor cells using recombinant adenovirus
Antitumor immune response and the success of cancer immunotherapy depend on the proper recognition of the tumor HLA class I complex (HLA class I heavy chain/ s2-microglobulin/peptide) by cytotoxicExpand
Non-immune Modulators of Cellular Immune Surveillance to HIV-1 and Other Retroviruses: Future Artificial Intelligence-Driven Goals and Directions
TLDR
Together, immune and non-immune cells and soluble factors act in concert to engender and sustain a finely tuned immune surveillance process, whose ultimate end (Y) is to regain homeostatic balance of the organism – a healthy state. Expand
Molecular mechanisms of MHC class I abnormalities and APM components in human tumors
  • B. Seliger
  • Biology, Medicine
  • Cancer Immunology, Immunotherapy
  • 2008
TLDR
The lack or downmodulation of the expression of single or multiple components of the MHC class I antigen processing pathway may avoid the recognition of tumor cells by tumor-specific CD8+ cytotoxic T lymphocytes. Expand
Analysis of transporter associated with antigen presentation (TAP) genes polymorphisms with HIV-1 infection
TLDR
A case–control analysis might suggest a possible role of TAP2 (A/G exon 11) (T665A) gene in the susceptibility to HIV-1 infection and disease outcome among North Indian patients. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 168 REFERENCES
Mutual interference of HIV and natural killer cell-mediated immune response.
TLDR
This review will focus on the mutual interference of NK cells and the HI virus, which can combat viral infection itself and opportunistic pathogens like fungi and protozoa that usually spread during the course of HIV infection. Expand
Human cytomegalovirus and natural killer‐mediated surveillance of HLA class I expression: a paradigm of host–pathogen adaptation
TLDR
The ability of HCMV to maintain surface levels of HLA‐E and to express an HLA class I surrogate (UL18) are herein discussed in the context of the interplay with human NKR systems. Expand
Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog
TLDR
The role of UL18 in NK cell recognition and lysis is examined using fibroblasts infected with either wild-type or UL18 knockout CMV virus, and by using cell lines transfected with the UL18 gene. Expand
Antigen presenting phenotype of Hodgkin Reed-Sternberg cells: analysis of the HLA class I processing pathway and the effects of interleukin-10 on epstein-barr virus-specific cytotoxic T-cell recognition.
TLDR
The results support the possibility that EBV-specific CTLs may be used to treat virus-positive HD and assess the antigen-presenting phenotype of H-RS cells. Expand
The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.
TLDR
Subpopulations of CTL and NK cells may be uniquely suited for combating HIV, and evidence that HIV-1 selectively downregulates HLA-A andHLA-B but does not significantly affect H LA-C or HLAE is presented. Expand
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.
TLDR
It is shown that, independently of the transporter associated with antigen processing, gpUL40 can up-regulate expression of HLA-E, which protects targets from NK cell lysis, which is up-regulated by HCMV. Expand
Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10.
TLDR
It is shown that vIL-10 affects the expression of one of the two transporter proteins (TAPs) associated with antigen presentation, and IL-10 causes a general reduction of surface MHC I molecules on B lymphocytes that might also affect the recognition of EBV-infected cells by cytotoxic T cells. Expand
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein
TLDR
It is shown that the expression of MHC–I at the surface of lymphoid, monocytic and epithelial cells was reduced in the presence of Nef protein from various HIV–1 strains, representing a previously undocumented viral mechanism for evading the immune response. Expand
Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease.
TLDR
The results suggest that global downregulation of MHC class I molecules does not account for the apparent ability ofEBV-infected HRS cells to evade CTL responses, but may be important in the understanding of EBV-negative disease. Expand
Direct Binding of Human Immunodeficiency Virus Type 1 Nef to the Major Histocompatibility Complex Class I (MHC-I) Cytoplasmic Tail Disrupts MHC-I Trafficking
TLDR
It is shown that purified Nef binds directly to the HLA-A2 cytoplasmic tail in vitro and that Nef forms complexes with MHC-I that can be isolated from human cells, providing the first direct evidence indicating thatNef functions as an adaptor molecule able to link M HC-I to cellular trafficking proteins. Expand
...
1
2
3
4
5
...